Postersessies NVVC Voorjaarscongres 2015

Size: px
Start display at page:

Download "Postersessies NVVC Voorjaarscongres 2015"

Transcription

1 Session Electrophysiology: Voorzitter: H.J.G.M. Crijns 1: Prediction of Response to Cardiac Resynchronization Therapy by the Misbalance in Regional Left Ventricular Myocardial Work A. Zweerink; G.J. de Roest; L. Wu; C.C. de Cock; A.C. van Rossum; C.P. Allaart (VU University Medical Center, Amsterdam) 2: Association of Apical Rocking with Long-Term Major Adverse Cardiac Events in Patients Undergoing Cardiac Resynchronization Therapy A. Ghani, P.P.H.M. Delnoy, A. Adiyaman, J.P. Ottervanger, A.R. Ramdat Misier, J.J.J. Smit, A. Elvan (Isala hospital, Zwolle) 3: High incidence of low esophageal temperatures during second generation cryoballoon therapy for atrial fibrillation M.M.D. Molenaar; M.F. Scholten; T. Hesselink; Y.J. Stevenhagen; J.M. van Opstal (Medisch Spectrum Twente, Enschede) 4: Efficacy and Safety of Catheter Ablation for Regular Supraventricular Tachycardia in a Starting Electrophysiology Centre J.P. Edel; B.A. Schoonderwoerd; H.A. Hauer; R.J. Folkeringa (MCL, Leeuwarden) 5: Acute Right Ventricular Apex Pacing with an Altered Ventricular Activation Pattern Reduces Eelectrical Parameters but Does Not Modify Torsade de Pointes Incidence in the Anesthetized Chronic Complete AV-block Dog A. Dunnink; R. Varkevisser; A. Bossu; S.C. Wijers; A. Oros; V.J.A. Bourgonje; T.R.G. Stams; H.D.M. Beekman; M.A. Vos (UMC Utrecht, Utrecht) 6: Characteristics and Failure Rate of the Biotronik Linox Implantable Cardioverter Defibrillator Lead F. Demirel; A. Adiyaman; P. P. Delnoy; J. J. J. Smit; A. R. Ramdat Misier; A. Elvan (Isala Klinieken, Zwolle) 7: Predictive Value of Local Prolonged Electro-Mechanical Interval in the Concealed Stage of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy TP Mast; AJ Teske; AS te Riele; JA Groeneweg; JF van der Heijden; BK Velthuis; P Loh; PA Doevendans; D Dooijes; JM de Bakker; RN Hauer; MJ Cramer (UMC Utrecht, Utrecht) 8: Time Course of TachyArrhythmias after Implantation of a Left Ventricular Assiste Device A. Yaksh; C. Kik; P. Knops; K. Zwiers; M.J.B. van Ettinger; M.C.J. de Wijs; P. van de Kemp; A.J.J.C. Bogers; N.M.S. de Groot (ErasmusMC, Rotterdam) 9: Electrophysiological Markers that can Guide High Rate Pacing to Avert Occurrence of Torsade de Pointes in the Chronic Atrioventricular Block Dog Model S.C. Wijers; A. Dunnink; H.D.M. Beekman; R. Varkevisser, A. Bossu; A. Aranda Hernández; M. Meine; M.A. Vos (University Medical Center Utrecht, Utrecht).

2 Session Myocardial imaging: Voorzitter: M.J.W. Götte 10: CMR Feature Tracking in Patients with MRI-Conditional Pacing Systems - Assessment of Regional Wall Motion A.W.M. van der Graaf; P. Bhagirath, E.A. van Dongen, S. Ghoerbien, M.J.W. Götte (HagaZiekenhuis, Den Haag) 11: N-terminal pro brain natriuretic peptide (NT-proBNP) correlates with echocardiographic signs of cardiotoxicity during HER2Neu-recepter blocking therapy in patients with HER2Neu-positive breast cancer C. Liesting, J.J. Brugts; M.J.M. Kofflard; S. Sprangers; M. Fouraux; G.E. Cramer; J.J.E.M. Kitzen; J.J. de Rooi; E. Boersma; M-D. Levin ((ASz, Dordrecht/ErasmusMC, Rotterdam) 12: Echocardiographic Features of Pulmonary Hypertension in Pulmonary Sarcoidosis Patients M.P. Huitema, V.M.M.Vorselaars, S. Boerman, J.C. Grutters, M.C. Post (St. Antonius Hospital) 13: Follow-up of the Pulmonary Right-to-Left Shunt With Transthoracic Contrast Echocardiography in Hereditary Haemorrhagic Telangiectasia V.M.M. Vorselaars; S.Velthuis; R.J. Snijder; C.J.J. Westermann; J-A. Vos; J.J. Mager; M.C. Post (St Antonius Hospital, Nieuwegein) 14: Assessment of Myocardial Viability After Acute Myocardial Infarction: A Head-To- Head Comparison of the Ferfusable Tissue Index by PET and Delayed Contrast Enhanced CMR S.A.J. Timmer, P.F.A. Teunissen, I. Danad, L.F.H.J. Robbers, P.G. Raijmakers, A.M. Beek, A.C. van Rossum, A.A. Lammertsma, N. van Royen, P. Knaapen (VUmc, Amsterdam) 15: Noninvasive Imaging of Repolarization Gives Insight in Arrhythmogenic Substrate M.J.M. Cluitmans; P.G.A. Volders (MUMC+, Maastricht) 16: Striving Towards an Optimal Hybrid SPECT/CCTA Imaging Protocol R.M. Kauling; J. Schaap; K. Nieman; W.B. Meijboom; M.C. Post; J.A. Van der Heyden; B.J. Rensing; J.F. Verzijlbergen (Erasmus Medical Center, Rotterdam)

3 Session Coronary artery disease/acs: Voorzitter: S.A.J. Chamuleau 17: Coronary Pressure and Flow Relationships in Humans: Phasic Analysis of Normal and Pathological Coronary Arteries and the Implications for Stenosis Assessment Guus de Waard; Sukhjinder Nijjer; Tim van de Hoef; Sayan Sen; Ricardo Petraco; Mauro Echavarria-Pinto; Martijn van Lavieren; Ibrahim Danad; Paul Knaapen; Javier Escaned; Jan Piek; Justin Davies; Niels van Royen (VUMC, Amsterdam) 18: Unstable coronary plaque characteristics are associated with high-sensitivity cardiac troponin T and N-terminal Pro-Brain Natriuretic Peptide S. Altintas; E.P.M. Cardinaels; M.O. Versteylen; I.A.P.G. Joosen; M. Seifert; J.E. Wildberger; H.J.G.M. Crijns; P.J. Nelemans; M.P. Van Dieijen-Visser; A.M.A. Mingels; M. Das; B.L.J.H. Kietselaer (Maastricht University Medical Center, Maastricht) 19: Anti-inflammatory compounds reduce infarct size after myocardial infarction: A meta-analysis of large-animal models G.P.J. van Hout, S.J. Jansen of Lorkeers, K.E. Wever, E.M. Sena, L.H.J.A. Kouwenberg, W.W. van Solinge, P.A. Doevendans, G. Pasterkamp, S.A.J. Chamuleau, I.E. Hoefer (UMC Utrecht, Utrecht) 20: Gender independent factor in atherosclerotic plaque characteristics. Data from ATHEROREMO-IVUS study M. ten Haaf; M. Rijndertse; J. Cheng; S. De Boer; H. Garcia Garcia; R. van Geuns; E. Regar; M. Lenzen; Y. Appelman; E. Boersma (Erasmus MC, Rotterdam) 21: Development of invasively measured Coronary Flow Reserve before and after reperfusion for acute myocardial infarction: results from an experimental porcine model and the human situation Guus de Waard; Paul Teunissen; Maurits Hollander; Matthijs Jansen; Lourens Robbers; Elise Eerenberg; Aernout Beek; Niels van Royen (VUMC, Amsterdam) 22: The Effect of Heparin and Bivalirudin on Periprocedural Platelet Reactivity in Patients Undergoing PCI P.W.A. Janssen; J. Krikke, E.A. Mol; T.C. Godschalk; G.J.A. Vos; K. Qaderdan; T.O. Bergmeijer; C.M. Hackeng; J.M. ten Berg (St. Antonius Ziekenhuis, Nieuwegein) 23: Evolution of VF during Prolonged Resuscitations: Study of Changes in VF Characteristics in Relation to the Chance of Return of Spontaneous Circulation J. Thannhauser; J.L. Bonnes; J. Nas; W. Keuper; M.J. de Boer; J.L.R.M. Smeets; M.A. Brouwer (Radboudumc, Nijmegen)

4 Session Valvular/structural disease: Voorzitter: J.W. Roos-Hesselink 24: Multidimensional Geriatric Assessment (MGA) in the Prediction of Delirium after Transcatheter Aortic Valve Implantation P. Assmann; H. Bor; K. Van der Wulp; M. Verkroost; H. Gehlmann; M. van Wely; L. Noyez; P. Kievit; Y. Schoon (Radboudumc, Nijmegen) 25: Transcatheter Aortic Valve Implantation With The New Balloon-Expandable SAPIEN 3 Versus SAPIEN XT Valve System: A Propensity Score Matched Single Center Comparison F. Nijhoff; M. Abawi; P. Agostoni; P. A. Doevendans; P. R. Stella (UMC-Utrecht) 26: Incidence, Impact and Predictive Factors of Delirium after Transcatheter Aortic Valve Implantation M. Abawi; F. Nijhoff; P. A. Doevendans; P. Agostoni; P. R. Stella (UMC-Utrecht) 27: Resveratrol Inhibits Aortic Root Dilatation in Marfan Mice S. Hibender; R. Franken; E.E. Schermer; I. van der Made; Y.M. Pinto; M. Groenink; A.H. Zwinderman; B.J.M. Mulder; C.J.M. de Vries; V de Waard (Academic Medical Center, Amsterdam) 28: Fragmented QRS complexes predict mortality in adults with tetralogy of Fallot J.P. Bokma; M.M. Winter; H.W. Vliegen; A.P. van Dijk; P.G. Pieper; F.J. Meijboom; M.C. Post; B.J.M. Mulder; B.J. Bouma (Academisch Medisch Centrum, Amsterdam) 29: Stent Implantation in Aortic Coarctation in Turner Syndrome: a Safety Analysis A.T. van den Hoven; Andreas Eicken; Jamil Aboulhosn; Christiaan de Bruin; P.F. Backelauw; A.L. Duijnhouwer; Laurent Demulier; Massimo Chessa; A. Uebing; A.E. van den Bosch; M. Witsenburg; J.W. Roos-Hesselink (Erasmus MC, Rotterdam) 30: Septal Myectomy does not improve Septal Myocardial Efficiency in Hypertrophic Cardiomyopathy A. Guclu; P. Knaapen; H.J. Harms; P. Klein; M. Michels; A.A. Lammertsma; A.C. van Rossum; T. Germans; J. van der Velden (VUmc, Amsterdam)

5 Session Genetics in cardiology: Voorzitter: M.J. de Boer 31: The Distribution Pattern of Fibrosis in Genetic Cardiomyopathy is Related to the Type of Pathogenic Mutation J.M.I.H. Gho; S. Sepehrkhouy; R. van Es; M. Harakalova; N. de Jonge; S.A.J. Chamuleau; R.A. de Weger; F.W. Asselbergs; A. Vink (UMC Utrecht) 32: Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome R. Franken; S. Wanga, A.W. den Hartog; T. Radonic; J. Timmermans; A.J. Scholte; M.P. van den Berg; A.H. Zwinderman; M. Groenink; B.J.M. Mulder; V. de Waard; G. Pals (VUMC, Amsterdam) 33: Aortic Dilation in Patients with Hereditary Haemorrhagic Telangiectasia and a SMAD4 Gene Mutation V.M.M. Vorselaars; J-A. Vos; S.Velthuis; R.J. Snijder; C.J.J. Westermann; J.J. Mager; M.C. Post (St Antonius Hospital, Nieuwegein) 34: Genetics of noncompaction cardiomyopathy (NCCM) J.I. van Waning, K. Caliskan, M. Michels, M.A. Slegtenhorst, D.F. Majoor-Krakauer (Erasmus MC, Rotterdam) 35: Prognosis in Dutch MYBPC3 Founder Mutation Carriers is Defined by Phenotype H.G. van Velzen; A.F.L. Schinkel; R.A. Oldenburg; M.A. van Slegtenhorst; I.M.E. Frohn Mulder, M. Michels (Erasmus MC, Rotterdam)

6 Session General cardiovascular disease: Voorzitter: C.E.E. van Ofwegen-Hanekamp 36: Effect of Beta-blocking Therapy on Cardiac Sympathetic Nerve Function in Patients with Idiopathic Pulmonary Arterial Hypertension M.T. Rijnierse; J.S. van Campen; K. de Boer; H.J. Harms; M.C. Huisman; P.G. Raijmakers; F.S. de Man; M.W. Heymans; A.A. Lammertsma; P. Knaapen; H.J. Boogaard; A. Vonk- Noordegraaf; C.P. Allaart (VU University Medical Center, Amsterdam) 37: Interpretation of Symptoms in Chest Pain Patients Is Gender Dependent: a Prospective Cohort Study M.G. van der Meer; Y. van der Graaf; H.M. Nathoe; P.A. Doevendans; B.E. Backus; A.J. Six; Y. Appelman (UMC Utrecht/VUmc, Amsterdam) 38: Dexamethasone for the Prevention of Postoperative Atrial Fibrillation D. van Osch; J.M. Dieleman; D. van Dijk; K.A. Jacob; J. Kluin; P.A. Doevendans; H.M. Nathoe (UMC, Utrecht) 39: Intraoperative High-Dose Dexamethasone in Cardiac Surgery and the Risk of Postoperative Bleeding Related Complications D. van Osch; J.M. Dieleman; H.M. Nathoe; M.P. Boasson; J. Kluin; J.J. Bunge; A.P. Nierich; P.M. Rosseel; J.M. van der Maaten; J. Hofland; J.C. Diephuis; F. de Lange; C. Boer; Diederik van Dijk (UMC, Utrecht) 40: Severity of Stable Coronary Artery Disease and its Biomarkers Differ Between Men and Women Undergoing Angiography C.M. Gijsberts; A. Gohar; I. E. Hoefer; D.P.V. de Kleijn; F. W. Asselbergs; H. M. Nathoe; P. Agostoni; S. Z.H. Rittersma; G. Pasterkamp; Y. Appelman; H. M. den Ruijter (UMC Utrecht) 41: Secondary Prevention after Myocardial Infarction in a Medium-sized Non-academic Hospital in the Netherlands D.N. van Dongen; E. Badings; E. van t Riet; F.M.A.C. Martens (Deventer ziekenhuis, Deventer) 42: All preclinical trials should be registered in advance in an online registry S.J. Jansen of Lorkeers, M. van der Naald) P.A. Doevendans, S.A.J. Chamuleau (UMC Utrecht, Utrecht) 43: Optimizing Pump Speed Promotes Synergy between Left Ventricular Assist Device and Right Ventricular Function in Patients on Long-Term Mechanical Assistance L.E. Couperus; V. Delgado; H.F. Verwey; L.F. Tops; M.J.H. Khidir, M. Palmen; R.J.M. Klautz; M.J. Schalij; S.L.M.A. Beeres (LUMC, Leiden) 44: The clinical relevance of myocardial injury after carotid endarterectomy R.B. Grobben; J.E.P. Vrijenhoek; H.M. Nathoe; J.A.R. van Waes; H.M. den Ruijter; L.M. Peelen; W.A. van Klei; G.J. de Borst (UMC Utrecht, Utrecht)

Rudolf de Boer. Paula Da Costa Martins. Ralph van Oort. Kevin Vernooij. Daniël Pijnappels. Lynda Juffermans. Toon van Veen. Peter van der Meer

Rudolf de Boer. Paula Da Costa Martins. Ralph van Oort. Kevin Vernooij. Daniël Pijnappels. Lynda Juffermans. Toon van Veen. Peter van der Meer Paula Da Costa Martins Ralph van Oort Lynda Juffermans Kevin Vernooij Daniël Pijnappels Toon van Veen Rudolf de Boer Linda van Laake Kim Van der Heiden Matthijs Boekholdt Peter van der Meer Blanche Schroen

More information

Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population. Carel Jan Willem Borleffs

Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population. Carel Jan Willem Borleffs Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population Carel Jan Willem Borleffs The studies described in this thesis were performed at the Department

More information

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957

More information

Innovation Platform: Sudden Cardiac Death

Innovation Platform: Sudden Cardiac Death Innovation Platform: Sudden Cardiac Death Prof. dr. Bart Loeys CRC Antwerp General Assembly VzW Board of Directors Strategic Advisory Board Staff: 1 executive director 1 ICT manager 1 financial administration

More information

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary

More information

INHERIT. The Lancet Diabetes & Endocrinology In press

INHERIT. The Lancet Diabetes & Endocrinology In press INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy a Randomized Intervention Trial with losartan Anna Axelsson, Kasper Iversen, Niels Vejlstrup, Carolyn

More information

Postoperative Myocardial Infarction: Diagnosis and Management

Postoperative Myocardial Infarction: Diagnosis and Management Postoperative Myocardial Infarction: Diagnosis and Management Todd M. Brown, MD, MSPH Chief Fellow Division of Cardiovascular Diseases December 9, 2008 CHEST PAIN NON-ANGINAL UNSURE ANGINAL STABLE ANGINA

More information

2012 ACCF/AHA/HRS Guidelines for Implantable Defibrillator and Cardiac Resynchronization Therapy for Cardiac Rhythm Abnormalities 1

2012 ACCF/AHA/HRS Guidelines for Implantable Defibrillator and Cardiac Resynchronization Therapy for Cardiac Rhythm Abnormalities 1 2012 ACCF/AHA/HRS Guidelines for Implantable Defibrillator and Cardiac Resynchronization for Cardiac Rhythm Abnormalities 1 Despite ICD and CRT being a Class I or IIa indication for treatment of patients,

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

Introduction to genetic testing and pharmacogenomics

Introduction to genetic testing and pharmacogenomics Introduction to genetic testing and pharmacogenomics Cecile Janssens Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands (a.janssens@erasmusmc.nl) Genetic prediction of monogenic diseases

More information

Cardiology ARCP Decision Aid August 2014

Cardiology ARCP Decision Aid August 2014 Cardiology ARCP Decision Aid August 2014 The table that follows includes a column for each training year which documents the targets that have to be achieved for a satisfactory ARCP outcome at the end

More information

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology Objectives Acute Coronary Syndromes Epidemiology and Health Care Impact Pathophysiology Unstable Angina NSTEMI STEMI Clinical Clues Pre-hospital Spokane County EMS Epidemiology About 600,000 people die

More information

List of Publications. Evaluation of stents and grafts. de Graaf FR, Schuijf JD. EuroIntervention 2010; 6 Suppl G: G48-56.

List of Publications. Evaluation of stents and grafts. de Graaf FR, Schuijf JD. EuroIntervention 2010; 6 Suppl G: G48-56. ist of Publications Diagnostic performance of 320-slice multidetector computed tomography coronary angiography in patients after coronary artery bypass grafting. de Graaf FR, van Velzen JE, Witkowska AJ,

More information

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications

More information

Utilizing the Cath Lab for Cardiac Arrest

Utilizing the Cath Lab for Cardiac Arrest Utilizing the Cath Lab for Cardiac Arrest Khaled M. Ziada, MD Director, Cardiovascular Catheterization Laboratories Gill Heart Institute, University of Kentucky UK/AHA Strive to Revive Symposium May 2013

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

A randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation

A randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation A randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation Gabriel Sayer Lay Abstract: Atrial fibrillation is a common form of irregular,

More information

Appropriate Use: Big Brother is Watching. Jason H. Rogers, MD Director, Interventional Cardiology UC Davis Medical Center

Appropriate Use: Big Brother is Watching. Jason H. Rogers, MD Director, Interventional Cardiology UC Davis Medical Center Appropriate Use: Big Brother is Watching Jason H. Rogers, MD Director, Interventional Cardiology UC Davis Medical Center Disclosures Consultant Boston Scientific, Medtronic, Middle Peak Medical, Millipede,

More information

Acute myocardial infarction, of other anterior wall, episode of care unspecified

Acute myocardial infarction, of other anterior wall, episode of care unspecified ICD-9 Description 395.0 Rheumatic aortic stenosis 395.1 Rheumatic aortic insufficiency 395.2 Rheumatic aortic stenosis with insufficiency 395.9 Other and unspecified rheumatic aortic diseases 396.0 Mitral

More information

Role of imaging: Insights from the cardiac catheterization?

Role of imaging: Insights from the cardiac catheterization? History and Clinical Presentation of Hypertrophic Cardiomyopathy Role of imaging: Insights from the cardiac catheterization? Stavros Hadjimiltiades MD, FACC, FACP Associate Professor in Cardiology Focal

More information

Potential Causes of Sudden Cardiac Arrest in Children

Potential Causes of Sudden Cardiac Arrest in Children Potential Causes of Sudden Cardiac Arrest in Children Project S.A.V.E. When sudden death occurs in children, adolescents and younger adults, heart abnormalities are likely causes. These conditions are

More information

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of

More information

1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA

1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA 1p36 and the Heart John Lynn Jefferies, MD, MPH, FACC, FAHA Director, Advanced Heart Failure and Cardiomyopathy Services Associate Professor, Pediatric Cardiology and Adult Cardiovascular Diseases Associate

More information

Coronary angiography in non intervention centers: is there a future? A. van der Sluis, cardiologist Deventer Ziekenhuis - Deventer

Coronary angiography in non intervention centers: is there a future? A. van der Sluis, cardiologist Deventer Ziekenhuis - Deventer Coronary angiography in non intervention centers: is there a future? A. van der Sluis, cardiologist Deventer Ziekenhuis - Deventer No disclosures Why is it an issue in the first place? Organization in

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

The clinical specialists view CARDIOLOGY

The clinical specialists view CARDIOLOGY 1st Symposium of the Amyloidosis Network The clinical specialists view CARDIOLOGY Andreas Flammer, MD, FESC University Heart Center Zurich Switzerland andreas.flammer@usz.ch Types of Amyloidosis affecting

More information

CARDIOVASCULAR DISORDERS

CARDIOVASCULAR DISORDERS Acute Decompensated Heart Failure: Time Critical Interventions MO-51 / 1 Hour Faculty: Matthew Strehlow, MD, FACEP Monday, 10/26/2015 / 3:30 PM - 4:20 PM The treatment of congestive heart failure (CHF)

More information

CURRICULUM VITAE. 2003 2006 Bachelor of Science, Psychology Faculty of Social and Behavioral Sciences, Tilburg University, Tilburg, Netherlands

CURRICULUM VITAE. 2003 2006 Bachelor of Science, Psychology Faculty of Social and Behavioral Sciences, Tilburg University, Tilburg, Netherlands CURRICULUM VITAE PERSONAL INFORMATION Date of birth: January 11, 1985 Nationality: Dutch Work address: Tilburg University Warandelaan 2 5037 AB Tilburg d.schoormans@uvt.nl EDUCATION 2003 2006 Bachelor

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

CTA OF THE EXTRACORONARY HEART

CTA OF THE EXTRACORONARY HEART CTA OF THE EXTRACORONARY HEART Charles White MD Director of Thoracic Imaging Department of Radiology University of Maryland NO DISCLOSURES CWHITE@UMM.EDU CARDIAC CASE DISTRIBUTION Coronary CTA 30% ED chest

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

ACLS Defibrillation Protocols With the ZOLL Rectilinear Biphasic Waveform AHA/ERC Guidelines 2005

ACLS Defibrillation Protocols With the ZOLL Rectilinear Biphasic Waveform AHA/ERC Guidelines 2005 ACLS Defibrillation Protocols With the ZOLL Rectilinear Biphasic Waveform AHA/ERC Guidelines 2005 Introduction: The purpose of this document is to outline the equivalent biphasic protocols specific to

More information

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation

More information

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department Sohil Pothiawala FAMS (EM), MRCSEd (A&E), M.Med (EM), MBBS Consultant Dept. of Emergency Medicine Singapore General Hospital

More information

Cardiovascular Genetics Center

Cardiovascular Genetics Center B r i g h a m a n d W o m e n s H o s p i t a l Cardiovascular Genetics Center Hypertrophic Cardiomyopathy Clinic The HCM Clinic at Brigham and Women s Hospital applies the latest scientific discoveries

More information

Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter

Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter 22 July 2010 EMA/CHMP/EWP/213056/2010 Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter Draft Agreed by Efficacy Working Party July 2008 Adoption by CHMP for release

More information

Protocol. Cardiac Rehabilitation in the Outpatient Setting

Protocol. Cardiac Rehabilitation in the Outpatient Setting Protocol Cardiac Rehabilitation in the Outpatient Setting (80308) Medical Benefit Effective Date: 07/01/14 Next Review Date: 09/15 Preauthorization No Review Dates: 07/07, 07/08, 05/09, 05/10, 05/11, 05/12,

More information

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics Yen Tibayan, M.D. Division of Cardiovascular Medicine Case Presentation 69 y.o. woman calls 911 with the complaint of

More information

Appendix. Costing Case Samples for OOHCA

Appendix. Costing Case Samples for OOHCA Appendix Costing Case Samples for OOHCA The patient (ICD-1) Treatment Codes (OPCS 4) Patient 27 Admitted to ICU following percutaneous cardiac intervention (PCI) with 2 drugeluting stents following a VF

More information

Prospective assessment of risk estimation models in pregnant women with congenital heart disease

Prospective assessment of risk estimation models in pregnant women with congenital heart disease Prospective assessment of risk estimation models in pregnant women with congenital heart disease Balci A, Sollie KM, Van der Bijl AG, Ruys PT, Mulder BJ, Roos-Hesselink JW, van Dijk AP, Wajon EM, Vliegen

More information

Automatic External Defibrillators

Automatic External Defibrillators Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

Team members: E.A.M. Verschuuren (captain), e.a.m.verschuuren@umcg.nl B. van der Blink, b.vanderblink@erasmusmc.nl H.G. Otten, h.g.otten@umcutrecht.

Team members: E.A.M. Verschuuren (captain), e.a.m.verschuuren@umcg.nl B. van der Blink, b.vanderblink@erasmusmc.nl H.G. Otten, h.g.otten@umcutrecht. NRS Roadmap Lung Transplantation Team members: E.A.M. Verschuuren (captain), e.a.m.verschuuren@umcg.nl B. van der Blink, b.vanderblink@erasmusmc.nl H.G. Otten, h.g.otten@umcutrecht.nl 1. Inventory of Dutch

More information

ECG may be indicated for patients with cardiovascular risk factors

ECG may be indicated for patients with cardiovascular risk factors eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,

More information

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory

More information

Cardiology. Cardiology Services

Cardiology. Cardiology Services Cardiology Cardiology Services Cardiology treats diseases that affect the heart and blood vessels. The human cardiovascular system pumps and circulates blood throughout the body, carrying oxygen and nutrients

More information

CAUSES AND PREVENTION OF CARDIORESPIRATORY ARREST

CAUSES AND PREVENTION OF CARDIORESPIRATORY ARREST CAUSES AND PREVENTION OF CARDIORESPIRATORY ARREST B1 Objectives To understand: The causes of cardiorespiratory arrest in adults How to identify patients at risk The role of a Medical Emergency Team The

More information

Electrocardiographic Issues in Williams Syndrome

Electrocardiographic Issues in Williams Syndrome Electrocardiographic Issues in Williams Syndrome R. Thomas Collins II, MD Assistant Professor, Pediatrics and Internal Medicine University of Arkansas for Medical Sciences Arkansas Children s Hospital

More information

Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses

Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses Diagnosis Code Crosswalk : to 402.01 Hypertensive heart disease, malignant, with heart failure 402.11 Hypertensive heart disease, benign, with heart failure 402.91 Hypertensive heart disease, unspecified,

More information

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts Cardiac Rehabilitation: From the other side of the glass door No disclosures, no conflicts Charles X. Kim, MD, FACC, ABVM Objectives 1. Illustrate common CV benefits of CV rehab in real world practice.

More information

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute Dual Antiplatelet Therapy Stephen Monroe, MD FACC Chattanooga Heart Institute Scope of Talk Identify the antiplatelet drugs and their mechanisms of action Review dual antiplatelet therapy in: The medical

More information

Platelet function in thrombocytopenia Mark Roest

Platelet function in thrombocytopenia Mark Roest Platelet function in thrombocytopenia Mark Roest Synapse Research Institute, Maastricht No Disclosures Trauma 1. Adhesion 2. Activation and Aggregation 3. Stable Aggregate Formation 4. Repair Platelet

More information

Heart Disorders Glossary

Heart Disorders Glossary Heart Disorders Glossary ABG (Arterial Blood Gas) Test: A test that measures how much oxygen and carbon dioxide are in the blood. Anemia: A condition in which there are low levels of red blood cells in

More information

Emergency Cardiac Surgery in Pregnancy and Post-partum Women

Emergency Cardiac Surgery in Pregnancy and Post-partum Women Emergency Cardiac Surgery in Pregnancy and Post-partum Women Phillips B. Harrington MD, Chris Piercecchi MD, Elise Bardawil MD, Jose Binongo PhD, Omar Lattouf MD 2-28-2016 Emory University Division of

More information

Le Cathétérisme Droit dans l HTAP: Pourqoi est-ce Indispensable?

Le Cathétérisme Droit dans l HTAP: Pourqoi est-ce Indispensable? Le Cathétérisme Droit dans l HTAP: Pourqoi est-ce Indispensable? Marco Roffi Médecin adjoint agrégé Responsable de l Unité de Cardiologie Interventionnelle HUG Diagnostic Work-up in Pulmonary Hypertension

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

Statins: Can there be too much of a good thing?

Statins: Can there be too much of a good thing? Statins: Can there be too much of a good thing? Spoiler alert No Oh Contraire Haaaaiiiiiiile No! Frequently under prescribing statin therapy! Typical Case 68 YO Smoker ACS Multiple prior PCI s Multiple

More information

Michigan Heart & Vascular Institute ON THE ST. JOSEPH MERCY HOSPITAL CAMPUS, ANN ARBOR, MICHIGAN

Michigan Heart & Vascular Institute ON THE ST. JOSEPH MERCY HOSPITAL CAMPUS, ANN ARBOR, MICHIGAN ON THE ST. JOSEPH MERCY HOSPITAL CAMPUS, ANN ARBOR, MICHIGAN Dear Colleague: Cardiovascular medicine has marked an important milestone in the battle against heart disease. The latest available data indicates

More information

Management of Symptomatic Atrial Fibrillation

Management of Symptomatic Atrial Fibrillation Management of Symptomatic Atrial Fibrillation John F. MacGregor, MD, FHRS Associate Medical Director, Cardiac Electrophysiology PeaceHealth St. Joseph Medical Center, Bellingham, WA September 18, 2015

More information

EXAMINATION QUESTIONS (V COURSE)

EXAMINATION QUESTIONS (V COURSE) EXAMINATION QUESTIONS (V COURSE) I. 1. Infective endocarditis. Definition. Etiology, pathogenesis, clinical manifestations. Diagnostic criteria, differential diagnosis, complications and outcomes. Treatment.

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

Diagnostic and Therapeutic Procedures

Diagnostic and Therapeutic Procedures Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Atrial Fibrillation An update on diagnosis and management

Atrial Fibrillation An update on diagnosis and management Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.

More information

Ngaire has Palpitations

Ngaire has Palpitations Ngaire has Palpitations David Heaven Cardiac Electrophysiologist/Heart Rhythm Specialist Middlemore, Auckland City and Mercy Hospitals Auckland Heart Group MCQ Ms A is 45, and a healthy marathon runner.

More information

CARDIOLOGY Delineation of Privileges

CARDIOLOGY Delineation of Privileges CARDIOLOGY Delineation of Privileges APPLICANT: INITIAL APPOINTMENT REQUIREMENTS: BASIC EDUCATION: M.D. or D.O. from an accredited school of medicine or osteopathy. Successful completion of an ACGME or

More information

TACHYCARDIA INDUCED CARDIOMYOPATHY. Case 1 ECG

TACHYCARDIA INDUCED CARDIOMYOPATHY. Case 1 ECG TACHYCARDIA INDUCED CARDIOMYOPATHY Javier E. Banchs M.D. Associate Professor of Medicine Penn State Hershey Heart & Vascular Institute Case 1 34 year old man with history of tachycardia x 6 months, nausea

More information

GERIATRYCZNE PROBLEMY KLINICZNE/GERIATRICS MEDICAL PROBLEMS

GERIATRYCZNE PROBLEMY KLINICZNE/GERIATRICS MEDICAL PROBLEMS 65 G E R I A T R I A 2011; 5: 65-69 GERIATRYCZNE PROBLEMY KLINICZNE/GERIATRICS MEDICAL PROBLEMS Otrzymano/Submitted: 24.02.2011 Poprawiono/Corrected: 01.03.2011 Zaakceptowano/Accepted: 06.03.2011 Akademia

More information

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology

More information

DATE: 29 August 2012 CONTEXT AND POLICY ISSUES

DATE: 29 August 2012 CONTEXT AND POLICY ISSUES TITLE: Dual Antiplatelet Therapy and Enoxaparin or Unfractionated Heparin for patients with ST-elevation Myocardial Infarction: A Review of the Clinical Evidence DATE: 29 August 2012 CONTEXT AND POLICY

More information

HFNEF HFNEF. Heart failure with normal ejection fraction, HFNEF Diastolic heart failure, DHF. CHARM-Preserved Trial 2 NYHA class II-IV

HFNEF HFNEF. Heart failure with normal ejection fraction, HFNEF Diastolic heart failure, DHF. CHARM-Preserved Trial 2 NYHA class II-IV 1. 2. 3. Heart failure with normal ejection fraction, HFNEF Diastolic heart failure, DHF relatively preserved systolic left ventricular function 1 LVEF < 40% HFNEF HFNEF CHARM-Preserved Trial 2 NYHA class

More information

Prognostic impact of baseline septal thickness and ethanol dose during long-term followup percutaneous septal ablation

Prognostic impact of baseline septal thickness and ethanol dose during long-term followup percutaneous septal ablation Prognostic impact of baseline septal thickness and ethanol dose during long-term followup percutaneous septal ablation Christian Prinz¹, Detlef Hering¹, Olaf Oldenburg¹, Dieter Horstkotte¹, Lothar Faber¹

More information

YES NO YES NO PENETRANCE ACTIONABILITY YES NO SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES (Proceed to Stage II) YES ( 1 of above) NO

YES NO YES NO PENETRANCE ACTIONABILITY YES NO SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES (Proceed to Stage II) YES ( 1 of above) NO Stage I: Rule Out Dashboard GENE/GENE PANEL: TNNT2, LMNA ACTIONABILITY 1. Is there a qualifying resource, such as a practice guideline or systematic review, for the genetic condition? 2. Does the practice

More information

Heart Disease: Diagnosis & Treatment

Heart Disease: Diagnosis & Treatment How I Treat Cardiology Peer Reviewed Heart Disease: Diagnosis & Treatment Amara Estrada, DVM, DACVIM (Cardiology) University of Florida Background Clinical heart disease is the stage of disease when a

More information

Adult Cardiac Surgery ICD9 to ICD10 Crosswalks

Adult Cardiac Surgery ICD9 to ICD10 Crosswalks 164.1 Malignant neoplasm of heart C38.0 Malignant neoplasm of heart 164.1 Malignant neoplasm of heart C45.2 Mesothelioma of pericardium 198.89 Secondary malignant neoplasm of other specified sites C79.89

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic

More information

SECOND CARDIOLOGY JOINT SEMINAR. Rome, April 12-13, 2012. Cardiovascular Center OLV Clinic Aalst Belgium. and

SECOND CARDIOLOGY JOINT SEMINAR. Rome, April 12-13, 2012. Cardiovascular Center OLV Clinic Aalst Belgium. and SECOND CARDIOLOGY JOINT SEMINAR Rome, April 12-13, 2012 Cardiovascular Center OLV Clinic Aalst Belgium and Cardiology Faculty of Medicine and Psychology Sapienza University, Rome, Italy Cardiology Sacred

More information

DISEASES OF THE CIRCULATORY SYSTEM

DISEASES OF THE CIRCULATORY SYSTEM DISEASES OF THE CIRCULATORY SYSTEM ACUTE RHEUMATIC FEVER (390 392.9) 390 RHEUMATIC FEVER WITHOUT MENTION OF HEART INVOLVEMENT 391 RHEUMATIC FEVER WITH HEART INVOLVEMENT 391.0 ACUTE RHEUMATIC PERICARDITIS

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

Endorsement Summary: Cardiovascular Measures

Endorsement Summary: Cardiovascular Measures January 2012 Purpose of the Project The human and financial costs of cardiovascular disease are enormous. Heart disease is the leading cause of death for men and women in the United States and was estimated

More information

Clinical Genetics in Heart Function Services

Clinical Genetics in Heart Function Services Clinical Genetics in Heart Function Services Dhavendra Kumar Consultant/ Hon. Professor Clinical Geneticist & Lead- Cardiovascular Genetics Institute of Medical Genetics University Hospital of Wales Cardiff

More information

E C C. American Heart Association. ACLS Provider. Written Examinations. August 2006

E C C. American Heart Association. ACLS Provider. Written Examinations. August 2006 E C C American Heart Association ACLS Provider Written Examinations Contents: Examination Memo Version A Answer Sheet Version A Exam Version A Answer Key Version A Annotations Version B Answer Sheet Version

More information

Recurrent AF: Choosing the Right Medication.

Recurrent AF: Choosing the Right Medication. In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department

More information

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine Sri Ramachandra University INTRODUCTION

More information

016 // Right Heart Disease

016 // Right Heart Disease 016 // Right Heart Disease CONTENTS 150 Basics of Pulmonary Hypertension 152 Echo Assessment of Pulmonary Hypertension 155 Disease of the Right Ventricle 155 Right Ventricular Infarction 156 Right Ventricular

More information

015 % 12 % 5 %, 15 % 20 %, Tsinghua Tongfang Optical Disc Co., Ltd. All rights reserved , 1 086,

015 % 12 % 5 %, 15 % 20 %, Tsinghua Tongfang Optical Disc Co., Ltd. All rights reserved , 1 086, 2003 3 42 3 Chin J Intern Med, March 2003, Vol 42, No. 3 157 2 ( ) 18 4 511, 1 086, 3 425, 24181 %, ( P < 01001) Logistic :75 ( OR 1176,95 % CI 11082198), ( OR 1152 ; 95 % CI 11281180), ( OR 1139,95 %

More information

Exploratory Study on the Future of Nephrology 2007

Exploratory Study on the Future of Nephrology 2007 Exploratory Study on the Future of Nephrology 2007 Summary Exploratory Study on the Future of Nephrology 2007 By Arjen Rienks Version: 29 October 2007 Summary version: 4 February 2008 Content 1. Introduction

More information

Platelet Function Testing vs Genotyping : Focus on Pharmacogenomics of Clopidogrel. Kiyuk Chang, M.D., Ph.D.

Platelet Function Testing vs Genotyping : Focus on Pharmacogenomics of Clopidogrel. Kiyuk Chang, M.D., Ph.D. Platelet Function Testing vs Genotyping : Focus on Pharmacogenomics of Clopidogrel Kiyuk Chang, M.D., Ph.D. Cardiovascular Center & Cardiology Division Seoul St. Mary s Hospital The Catholic University

More information

Chest Pain in Young Athletes. Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego cdavis@rchsd.

Chest Pain in Young Athletes. Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego cdavis@rchsd. Chest Pain in Young Athletes Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego cdavis@rchsd.org 858-966-5855 None Disclosures Chest Pain: the good news and the bad news:

More information

Chronic Vagus Nerve Stimulation: A New Treatment Modality for Congestive Heart Failure

Chronic Vagus Nerve Stimulation: A New Treatment Modality for Congestive Heart Failure Chronic Vagus Nerve Stimulation: A New Treatment Modality for Congestive Heart Failure Gaetano M. De Ferrari, MD Dept. of Cardiology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy for the CardioFit

More information

INTRODUCTION TO EECP THERAPY

INTRODUCTION TO EECP THERAPY INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and

More information

SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE

SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE Summary Heart failure has a worse prognosis than many cancers with an annual mortality of 40% in the first year following diagnosis and 10% thereafter.

More information

The author has no disclosures

The author has no disclosures Mary Bradbury, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Surgery September 18, 2012 Mary.bradbury@inova.org This presentation will discuss unlabeled and investigational use of products The author

More information

Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges

Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges NAME Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges GENERAL CARDIOLOGY Required Qualifications for General Cardiology Education/Training/Experience Must have

More information

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated

More information

NEW ADVANCES IN MYOCARDIAL INFARCTION THERAPY: THE REGENERATION APPROACH

NEW ADVANCES IN MYOCARDIAL INFARCTION THERAPY: THE REGENERATION APPROACH NEW ADVANCES IN MYOCARDIAL INFARCTION THERAPY: THE REGENERATION APPROACH Giovanni Esposito, MD, PhD Dipartimento di Cardiologia, Cardiochirurgia ed Emergenze Cardiovascolari Laboratorio di Emodinamica

More information

Failure or significant adverse effects to all of the alternatives: Eliquis and Xarelto

Failure or significant adverse effects to all of the alternatives: Eliquis and Xarelto This policy has been developed through review of medical literature, consideration of medical necessity, generally accepted medical practice standards, and approved by the IEHP Pharmacy and Therapeutics

More information